These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9659856)

  • 1. Effects of antidepressant treatment on neuroactive steroids in major depression.
    Romeo E; Ströhle A; Spalletta G; di Michele F; Hermann B; Holsboer F; Pasini A; Rupprecht R
    Am J Psychiatry; 1998 Jul; 155(7):910-3. PubMed ID: 9659856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.
    Ströhle A; Romeo E; Hermann B; Pasini A; Spalletta G; di Michele F; Holsboer F; Rupprecht R
    Biol Psychiatry; 1999 Feb; 45(3):274-7. PubMed ID: 10023501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sleep deprivation on neuroactive steroids in major depression.
    Schüle C; di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2003 Mar; 28(3):577-81. PubMed ID: 12629540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC; di Michele F; Schüle C; Eser D; Zwanzger P; Pasini A; Romeo E; Rupprecht R
    Neuropsychopharmacology; 2005 Jun; 30(6):1181-6. PubMed ID: 15702138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
    Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of electroconvulsive therapy on plasma levels of neuroactive steroids in inpatients with major depression.
    Turan Ş; Yıldırım A; Aksoy-Poyraz C; Bolayırlı M; Savrun M
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):261-4. PubMed ID: 25000174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A; Romeo E; di Michele F; Pasini A; Yassouridis A; Holsboer F; Rupprecht R
    Am J Psychiatry; 2002 Jan; 159(1):145-7. PubMed ID: 11772707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder.
    Bicíková M; Tallová J; Hill M; Krausová Z; Hampl R
    Neurochem Res; 2000 Dec; 25(12):1623-7. PubMed ID: 11152391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.
    Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA
    Psychoneuroendocrinology; 2016 Aug; 70():98-107. PubMed ID: 27209438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers.
    Rupprecht R; Ströhle A; Hermann B; di Michele F; Spalletta G; Pasini A; Holsboer F; Romeo E
    Biol Psychiatry; 1998 Nov; 44(9):912-4. PubMed ID: 9807647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroactive steroids and affective disorders.
    Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction.
    Hill M; Popov P; Havlíková H; Kancheva L; Vrbíková J; Kancheva R; Pouzar V; Cerný I; Stárka L
    Steroids; 2005 Jul; 70(8):515-24. PubMed ID: 15894035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile.
    Girdler SS; Lindgren M; Porcu P; Rubinow DR; Johnson JL; Morrow AL
    Psychoneuroendocrinology; 2012 Apr; 37(4):543-53. PubMed ID: 21890277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.